Acer Therapeutics Compliant with All Nasdaq Listing

NEWTON, Mass., Dec. 29, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development...

Related Keywords

Jim Denike ,Nick Colangelo ,Gilmartin Group ,Nasdaq Stock Market ,Acer Therapeutics Inc ,Nasdaq Hearings Panel ,Nasdaq ,Nasdaq Capital ,Maple Syrup Urine Disease ,Vasomotor Symptoms ,Post Traumatic Stress Disorder ,Nasdaq Acer ,